Contact
Please use this form to send email to PR contact of this press release:
Results of Phase 2 Study of Merck’s Investigational Beta-Lactamase Inhibitor Relebactam Presented at ICAAC/ICC 2015
TO:
Please use this form to send email to PR contact of this press release:
Results of Phase 2 Study of Merck’s Investigational Beta-Lactamase Inhibitor Relebactam Presented at ICAAC/ICC 2015
TO: